Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression

Por Bukur, Juergen, Herrmann, Felix, Handke, Diana, Recktenwald, Christian, Seliger, Barbara
Publicado em 2010

Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma

Por Seliger, Barbara, Handke, Diana, Schabel, Elisabeth, Bukur, Juergen, Lichtenfels, Rudolf, Dammann, Reinhard
Publicado em 2009

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer

Por Seliger, Barbara, Stoehr, Robert, Handke, Diana, Mueller, Anja, Ferrone, Soldano, Wullich, Bernd, Tannapfel, Andrea, Hofstaedter, Ferdinand, Hartmann, Arndt
Publicado em 2009

Characterizing CD44 regulatory microRNAs as putative therapeutic agents in human melanoma

Por Fänder, Johannes, Kielstein, Heike, Büttner, Maximilian, Koelblinger, Peter, Dummer, Reinhard, Bauer, Marcus, Handke, Diana, Wickenhauser, Claudia, Seliger, Barbara, Jasinski-Bergner, Simon
Publicado no Oncotarget (2019)

Role of signal transduction and microRNAs on the immunogenicity of melanoma cells

Por Meyer, Stefanie, Handke, Diana, Mueller, Anja, Meinhardt, Anne, Jasinski-Bergner, Simon, Mages, Stephan, Bukur, Juergen, Donia, Marco, Straten, PerThor, Seliger, Barbara
Publicado no J Transl Med (2015)

Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients

Por Lazaridou, Maria-Filothei, Gonschorek, Evamaria, Massa, Chiara, Friedrich, Michael, Handke, Diana, Mueller, Anja, Jasinski-Bergner, Simon, Dummer, Reinhard, Koelblinger, Peter, Seliger, Barbara
Publicado no Oncoimmunology (2020)